Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable locally advanced (UR-LA) pancreatic ductal adenocarcinoma.
Shimomura O, Oda T, Hashimoto S, Doi M, Hiroshima Y, Numajiri H, Takahashi K, Furuya K, Miyazaki Y, Owada Y, Ogawa K, Ohara Y, Hisakura K, Akashi Y, Enomoto T, Sakurai H. Shimomura O, et al. Among authors: numajiri h. Surg Oncol. 2021 Jun;37:101542. doi: 10.1016/j.suronc.2021.101542. Epub 2021 Mar 13. Surg Oncol. 2021. PMID: 33740629 Free article.
A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma.
Abei M, Okumura T, Fukuda K, Hashimoto T, Araki M, Ishige K, Hyodo I, Kanemoto A, Numajiri H, Mizumoto M, Sakae T, Sakurai H, Zenkoh J, Ariungerel G, Sogo Y, Ito A, Ohno T, Tsuboi K. Abei M, et al. Among authors: numajiri h. Radiat Oncol. 2013 Oct 16;8:239. doi: 10.1186/1748-717X-8-239. Radiat Oncol. 2013. PMID: 24131485 Free PMC article. Clinical Trial.
Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer.
Kanemoto A, Okumura T, Ishikawa H, Mizumoto M, Oshiro Y, Kurishima K, Homma S, Hashimoto T, Ohkawa A, Numajiri H, Ohno T, Moritake T, Tsuboi K, Sakae T, Sakurai H. Kanemoto A, et al. Among authors: numajiri h. Clin Lung Cancer. 2014 Mar;15(2):e7-12. doi: 10.1016/j.cllc.2013.11.002. Epub 2013 Nov 13. Clin Lung Cancer. 2014. PMID: 24365049
Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy.
Mizumoto M, Oshiro Y, Okumura T, Fukuda K, Fukumitsu N, Abei M, Ishikawa H, Ohnishi K, Numajiri H, Tsuboi K, Sakurai H. Mizumoto M, et al. Among authors: numajiri h. Radiother Oncol. 2014 Oct;113(1):54-9. doi: 10.1016/j.radonc.2014.08.015. Epub 2014 Sep 20. Radiother Oncol. 2014. PMID: 25248924
Proton beam therapy for metastatic liver tumors.
Fukumitsu N, Okumura T, Takizawa D, Makishima H, Numajiri H, Murofushi K, Ohnishi K, Mizumoto M, Aihara T, Ishikawa H, Tsuboi K, Sakurai H. Fukumitsu N, et al. Among authors: numajiri h. Radiother Oncol. 2015 Nov;117(2):322-7. doi: 10.1016/j.radonc.2015.09.011. Epub 2015 Sep 15. Radiother Oncol. 2015. PMID: 26385268
78 results